Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

5-MeO-DALT: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
← Older editNewer edit →
>White
m Text replacement - "{{Main|Serotonergic psychedelic}}" to "{{Further|Serotonergic psychedelic}}"
>White
m Text replacement - "{| |- | 17px''Main articles: Research chemicals § Toxicity and harm potential'' ''&'' ''Responsible use § Hallucinogens'' |}" to "{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}"
Line 65: Line 65:


==Toxicity and harm potential==
==Toxicity and harm potential==
{|  
{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}
|-
| [[File:Lolol.png|17px]]''Main articles: [[Research chemicals#Toxicity and harm potential|Research chemicals § Toxicity and harm potential]]'' ''&'' ''[[Responsible use #Hallucinogens|Responsible use § Hallucinogens]]''
|}
The toxicity and long-term health effects of recreational 5-MeO-DALT use do not seem to have been studied in any scientific context and the exact [[Toxicity::toxic dose is unknown]]. This is because 5-MeO-DALT is a [[research chemical]] with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried 5-MeO-DALT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption.  
The toxicity and long-term health effects of recreational 5-MeO-DALT use do not seem to have been studied in any scientific context and the exact [[Toxicity::toxic dose is unknown]]. This is because 5-MeO-DALT is a [[research chemical]] with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried 5-MeO-DALT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption.  
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this drug.
It is strongly recommended that one use [[responsible drug use|harm reduction practices]] when using this drug.

Revision as of 15:20, 20 March 2017

5-MeO-DALT
Chemical Nomenclature
Common names 5-MeO-DALT, Foxtrot
Substitutive name N,N-Diallyl-5-methoxytryptamine
Systematic name N-Allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine
Class Membership
Psychoactive class Psychedelic
Chemical class Tryptamine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.


⇣ Smoked
Dosage
Threshold 3 mg
Common 5 - 10 mg
Duration
Total 15 - 20 minutes
Onset 15 - 30 seconds
Come up 15 - 30 seconds
Peak 1 - 5 minutes
Offset 5 - 10 minutes
After effects 5 - 10 minutes
⇣ Oral
Dosage
Threshold 4 mg
Light 5 - 12 mg
Common 12 - 25 mg
Strong 25 - 35 mg
Heavy 35 mg +
Duration
Total 2 - 4 hours Tihkal
Onset 10 - 15 minutes
Come up 15 - 20 minutes
Peak 60 - 90 minutes
Offset 1 - 2 hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

Interactions
2C-T-X
2C-X
Cannabis
DOx
MDMA
Mescaline
NBOMe
Amphetamines
Cocaine
DXM
Tramadol
aMT
MAOIs
PCP
Summary sheet: 5-MeO-DALT

5-MeO-DALT, or N,N-diallyl-5-methoxytryptamine, is a psychedelic tryptamine first synthesized by Alexander Shulgin. It is chemically related to the compounds 5-MeO-DPT and DALT. It is described as having rapid, intense and short-acting entheogenic effects.

Alexander Shulgin sent the first material regarding the synthesis and effects of 5-MeO-DALT to a researcher in May 2004; afterwards, it soon circulated online. In June 2004, it became available through the use of online research chemical vendors. In August 2004, the synthesis and effects of 5-MeO-DALT were published by Erowid.[1]

Chemistry

5-MeO-DALT is named for its chemical structure 5-MEthOxy-Di-ALlyl-Tryptamine. It contains two allyl groups bound to the amino group and a 5-methoxy group bound to the indole ring of tryptamine. It is analogous to DALT and 5-MeO-DPT. At room temperature, 5-MeO-DALT is an off-white powder.

Pharmacology

Further information: Serotonergic psychedelic

5-MeO-DALT acts as a 5-HT2A partial agonist. The psychedelic effects are believed to come from its efficacy at the 5-HT2A receptors. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

Subjective effects

Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.

It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.

Physical effects

Cognitive effects

The head space of 5-MeO-DALT is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high doses.

Visual effects

Enhancements

Distortions

Geometry

The visual geometry that is present throughout the experience can be described as more similar in appearance to that of AMT than that of LSD, 2C-B or 2C-I. It can be comprehensively described as unstructured in its organization, synthetic in geometric style, intricate in complexity, small in size, slow and smooth in motion, colourful in scheme, glossy in colour, equally blurred and sharp in its edges and equally rounded and angular in its corners. It gives off a synthetic feel that is less impressive than most of the "classical" psychedelics at any level. It has yet to be confirmed whether this compound results in either level 8A or level 8B geometry at heavy doses.

Auditory effects

Experience reports

There are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:

Toxicity and harm potential

Further information: Research chemicals § Toxicity and harm potential, and Responsible use § Hallucinogens

The toxicity and long-term health effects of recreational 5-MeO-DALT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because 5-MeO-DALT is a research chemical with very little history of human usage. Anecdotal evidence from people within the psychonaut community who have tried 5-MeO-DALT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption. It is strongly recommended that one use harm reduction practices when using this drug.

Tolerance and addiction potential

5-MeO-DALT is not habit-forming and the desire to use it can actually decrease with use. It is most often self-regulating.

Tolerance to the effects of 5-MeO-DALT are built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). 5-MeO-DALT presents cross-tolerance with [[Cross-tolerance::all psychedelics]], meaning that after the consumption of 5-MeO-DALT all psychedelics will have a reduced effect.

  • United Kingdom - 5-MeO-DALT became a Class A drug in the United Kingdom on January 7th, 2015 after an update to the tryptamine blanket ban.[2]
  • Japan - 5-MeO-DALT became a controlled substance in Japan in April 2007 due to an amendment to the Pharmaceutical Affairs Law.[3]
  • Sweden - 5-MeO-DALT is a Schedule I substance in Sweden as of May 1, 2012. It was published by Medical Products Agency in their regulation LVFS 2012:6.[4]
  • United States - 5-MeO-DALT is not scheduled at the federal level in the United States and is therefore legal to buy, posses, and sell.[5] It is likely that it could be considered an analog (of 5-MeO-DiPT or another tryptamine), in which case sales or possession intended for human consumption could be prosecuted under the Federal Analogue Act.
    • Florida - 5-MeO-DALT is a Schedule I controlled substance in the state of Florida, making it illegal to buy, sell, or possess.[6]

See also

References

  1. ↑ http://www.vice.com/en_uk/read/the-last-interview-with-alexander-shulgin-423-v17n5
  2. ↑ http://www.legislation.gov.uk/uksi/2014/3277/pdfs/uksi_20143277_en.pdf
  3. ↑ "厚生労働省：平成１8年度無承認無許可医薬品等買上調査の結果について". Retrieved 2012-06-26. 
  4. ↑ http://www.lakemedelsverket.se/upload/lvfs/LVFS_2012_6.pdf
  5. ↑ §1308.11 Schedule I.
  6. ↑ Florida Statutes - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL
Retrieved from "http://psy.st/w/index.php?title=5-MeO-DALT&oldid=82733"